<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04175678</url>
  </required_header>
  <id_info>
    <org_study_id>31568-01</org_study_id>
    <nct_id>NCT04175678</nct_id>
  </id_info>
  <brief_title>Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men</brief_title>
  <official_title>Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a controlled, randomized clinical trial to show that diet, exercise training, and&#xD;
      their combination in overweight, physically inactive men will alter epigenetic programming to&#xD;
      create a &quot;healthy&quot; sperm epigenome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will recruit 20 normal weight, active men and 80 obese, inactive men to&#xD;
      compare their sperm epigenome at their baseline state.&#xD;
&#xD;
      The investigators will randomize the 80 obese, inactive men to intervention or no&#xD;
      intervention for 12 weeks:1) observation with clinic visits; 2) low fat/low caloric diet; 3)&#xD;
      supervised periodized strength and endurance training; and 4) low fat/ low caloric diet plus&#xD;
      exercise training. The investigators will compare changes in their sperm epigenome within&#xD;
      each group before and after intervention, between groups after intervention including the&#xD;
      non-obese,active men at baseline.&#xD;
&#xD;
      The investigators will follow the 80 men in the intervention groups and re-examined their&#xD;
      sperm epigenome at 12 weeks and then another 24 weeks after cessation of treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 21, 2020</start_date>
  <completion_date type="Anticipated">March 3, 2025</completion_date>
  <primary_completion_date type="Anticipated">March 3, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diet and Exercise Modulate the Sperm Epigenome in Men</measure>
    <time_frame>5 years</time_frame>
    <description>Compare alterations in the sperm epigenome (DNA methylation, histone modifications, non-coding RNAs) in obese, physically inactive men before and after diet modulation and/or exercise training or no intervention, both within and between groups.</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Healthy Lifestyle</condition>
  <condition>Obese</condition>
  <condition>Men</condition>
  <arm_group>
    <arm_group_label>Normal/Active</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese/Inactive</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Observational clinic visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>low fat/low caloric diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>≥3 sessions with fitness trainer per week, for ≥30 min, at moderate to high intensity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet and exercise training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>low fat/low caloric diet and ≥3 sessions with fitness trainer per week, for ≥30 min, at moderate to high intensity</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet</intervention_name>
    <description>Participants will receive delivered meals every 4 weeks for three months of a variety of foods for breakfast, lunch, dinner, two snacks, and an additional snack or dessert for each day.</description>
    <arm_group_label>Diet</arm_group_label>
    <arm_group_label>Diet and exercise training</arm_group_label>
    <other_name>low fat/low cal diet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Training will be supervised, individualized, and periodized, incorporating 3 sessions per week, 45-60 min per session for 36 sessions.</description>
    <arm_group_label>Diet and exercise training</arm_group_label>
    <arm_group_label>Exercise Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male volunteers in good health as confirmed by physical examination, medical history,&#xD;
             and clinical laboratory tests of blood and urine within the reference range at the&#xD;
             time of screening&#xD;
&#xD;
          2. Must have Hispanic Father and Mother from Mexico or Central America&#xD;
&#xD;
          3. Normal weight, active subjects:&#xD;
&#xD;
               -  BMI 18.5 - 24.9 calculated as weight in Kg/ (height in cm)2&#xD;
&#xD;
               -  Participates in ≥150 min/week of moderate intensity physical activity as assessed&#xD;
                  by accelerometer&#xD;
&#xD;
               -  Consume &lt; 30% of calories as fat/day&#xD;
&#xD;
               -  Fasting lipid panel within reference range or not clinically significant above&#xD;
                  the reference ranges&#xD;
&#xD;
             Obese and physically inactive subjects:&#xD;
&#xD;
               -  BMI ≥ 30 calculated as weight in Kg/ (height in cm)2 in obese subjects&#xD;
&#xD;
               -  Have risk factors for developing type 2 diabetes (first degree relatives with&#xD;
                  DM2, BP≥130/80, HDL-cholesterol ≤ 35mg/dL or triglycerides ≥200mg/dL, fasting&#xD;
                  plasma glucose ≥100mg/dl to 125mg/dL or HgbA1c ≥ 5.7 to 6.4%, abnormal liver&#xD;
                  transaminases (not more than 3 times upper limit of normal suggestive of hepatic&#xD;
                  steatosis)&#xD;
&#xD;
               -  Participates in ≤150 min/week of moderate intensity physical activity&#xD;
&#xD;
               -  Consume &gt;30 % fat as calories/day&#xD;
&#xD;
               -  Stable weight for past six months prior to the first screening visit&#xD;
&#xD;
               -  Willing to commit to 12 weeks of three times a week personalized exercise&#xD;
                  training&#xD;
&#xD;
               -  Willing to commit to 12 weeks of weight loss diet (low fat and low calories)&#xD;
&#xD;
          4. In the opinion of the investigator, subject is able to comply with the protocol,&#xD;
             understand and sign an informed consent and HIPAA form&#xD;
&#xD;
          5. Does not meet any of the exclusion criteria.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Men who meet any of the following criteria are NOT eligible for enrollment in the&#xD;
             trial:&#xD;
&#xD;
          2. Men participating in another clinical trial within the last 30 days prior to the first&#xD;
             screening visit&#xD;
&#xD;
          3. Men not living in the catchment's area of the clinic or within a reasonable distance&#xD;
             from the site&#xD;
&#xD;
          4. Clinically significant abnormal findings at screening except for those stated above&#xD;
             for the obese, inactive group&#xD;
&#xD;
          5. Abnormal serum chemistry values, according to local laboratory normal values that&#xD;
             indicate chronic liver or kidney dysfunction or that may be considered clinically&#xD;
             significant (except for obesity related abnormal laboratory tests including blood&#xD;
             glucose, Hgb A1c, liver transaminases, lipids for the obese, active group as stated&#xD;
             above). Other abnormal lab values may also be exclusionary, at the discretion of the&#xD;
             investigator&#xD;
&#xD;
          6. Sperm concentration below 15 million/mL in more than one of three screening samples&#xD;
&#xD;
          7. Diastolic (D) blood pressure (BP) &gt; 30 and Systolic (S) BP &gt; 130 mm Hg for the&#xD;
             healthy, non-obese and active group; and diastolic (D) blood pressure (BP) &gt; 150 and&#xD;
             Systolic (S) BP &gt; 100 mm Hg for the obese, inactive group on in the opinion of the&#xD;
             investigator not suitable for exercise training (BP will be taken 3 times at 5 minute&#xD;
             intervals and the mean of all measurements be considered)&#xD;
&#xD;
          8. History of hypertension, including hypertension controlled with treatment in the&#xD;
             healthy, active group&#xD;
&#xD;
          9. Known history of reproductive dysfunction including vasectomy or infertility&#xD;
&#xD;
         10. Known history of cardiac, renal, hepatic, cardiac or respiratory disease&#xD;
&#xD;
         11. A serious systemic disease such as diabetes mellitus defined by the American Diabetes&#xD;
             Association or morbid obesity (body weight greater than 120% of ideal body weight or&#xD;
             BMI limitation as above)&#xD;
&#xD;
         12. Known or suspected alcoholism or drug abuse or chronic infections&#xD;
&#xD;
         13. Serious digestive and/or absorptive problems, including inflammatory bowel disease and&#xD;
&#xD;
         14. Chronic food intolerance or diarrhea that preclude adherence to the study diet.&#xD;
&#xD;
         15. Cardiovascular, respiratory or musculoskeletal disease or joint problems that preclude&#xD;
             moderate physical activity.&#xD;
&#xD;
         16. Psychiatric disorders (including eating disorders) or conditions that, in the opinion&#xD;
             of the investigator, would preclude participation in the study intervention (e.g.&#xD;
             untreated major depression or psychosis, substance abuse, severe personality&#xD;
             disorder).&#xD;
&#xD;
         17. History of other malignancies except: adequately treated non-melanoma skin cancer&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Lundquist Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christina Wang, MD</last_name>
    <phone>310-222-2503</phone>
    <email>wang@lundquist.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Lundquist Institute</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Ruiz</last_name>
      <phone>310-222-1728</phone>
      <email>eruiz@labiomed.org</email>
    </contact>
    <contact_backup>
      <last_name>Xiaodan Han</last_name>
      <phone>310-222-1865</phone>
      <email>xhan@labiomed.org</email>
    </contact_backup>
    <investigator>
      <last_name>Ronald Swerdloff, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 21, 2019</study_first_submitted>
  <study_first_submitted_qc>November 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2019</study_first_posted>
  <last_update_submitted>January 26, 2021</last_update_submitted>
  <last_update_submitted_qc>January 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hispanic Men</keyword>
  <keyword>Healthy Men</keyword>
  <keyword>Obese Men</keyword>
  <keyword>Exercise</keyword>
  <keyword>Diet</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

